Placebo Effects in Neurologic Disease

Erscheinungsjahr 2020
ISBN: 978-0-12-821118-2
Verlag: William Andrew Publishing

Buch, Englisch, 278 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 570 g

Placebo Effects in Neurologic Disease, Volume 153, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on Background and Methods in Placebo, Better than Nothing: A Historical Account of Placebos and Placebo Effects from Modern to Contemporary Medicine, Determinants of PE, Strategies for Minimizing PE in Research, Maximizing placebo response in the clinic, Statistical methods for handling PE, Nocebo and Lessebo effects, Ethics of deception, Pain, Parkinson's Disease, Cognitive impairment, Epilepsy, and much more.

Zielgruppe

<p>Undergraduates, graduates, academics and researchers in the field of  Neurologic Disease</p>

Autoren/Hrsg.

Weitere Mitwirkende

Witek, Natalie P

Goetz, Christopher G.

Stebbins, Glenn

Fachgebiete

• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Naturwissenschaften Biowissenschaften Biowissenschaften Neurobiologie, Verhaltensbiologie

Inhaltsverzeichnis

Part 1: Background and methods in placebo

- Better than nothing: A historical account of placebos and placebo effects from modern to contemporary medicine

Marco Annoni

- Determinants of placebo effects

Sharlet Anderson and Glenn T. Stebbins

- Strategies to minimize placebo effects in research investigations

Filipe B Rodrigues and Joaquim J Ferreira

- Maximizing placebo response in neurological clinical practice

Louise-Laure Mariani and Jean-Christophe Corvol

- Statistical methods in handling placebo effect

Rema Raman

- Nocebo and lessebo effects

Tiago A. Mestre

- Deception and the ethics of placebo

A. Jon Stoessl

Part 2: Placebo response in specific disease populations

- Placebo effects in pain

Luana Colloca

- Placebo responses in Parkinson's disease

Jau-Shin Lou

- Placebo effect in subjects with cognitive impairment

Kaori Ito and Klaus Romero

- Placebo in epilepsy

Daniel M. Goldenholz and Shira R. Goldenholz

Über Autor(innen)

Witek, Natalie P
Natalie Witek is at Rush Parkinson's Disease and Movement Disorders Program, USA

Goetz, Christopher G.
Professor and Associate Chairman, Department of Neurological Sciences, Rush University, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL Professor of Neurological Science

Stebbins, Glenn
Glenn Stebbins is at Rush Parkinson's Disease and Movement Disorders Program, USA